Akebia Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.09 | -$0.05 | -$0.07 |
| Q2 2024 | 1 | -$0.09 | -$0.05 | -$0.07 |
| Q3 2024 | 1 | -$0.07 | -$0.05 | -$0.06 |
| Q4 2024 | 2 | -$0.08 | -$0.02 | -$0.06 |
| Q1 2025 | 2 | -$0.16 | $0.01 | -$0.08 |
| Q2 2025 | 1 | -$0.10 | -$0.06 | -$0.09 |
| Q3 2025 | 1 | -$0.06 | -$0.04 | -$0.05 |
| Q4 2025 | 1 | -$0.03 | -$0.02 | -$0.03 |
Akebia Therapeutics, Inc. Earnings Date And Information
Akebia Therapeutics, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.1 earnings per share for the quarter, missing analysts' consensus estimates of $-0.05 by $0.05. The company had revenue of 35.59 M for the quarter and had revenue of 194.62 M for the year. Akebia Therapeutics, Inc. has generated $0 earnings per share over the last year ($-0.28 diluted earnings per share) and currently has a price-to-earnings ratio of -8.78. Akebia Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based on prior year's report dates.
Akebia Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.05 | -$0.10 | -0.05 | $44.50 M | $35.59 M |
| 08/08/2024 | Q2 2024 | -$0.06 | -$0.04 | 0.02 | $49.80 M | $43.65 M |
| 05/09/2024 | Q1 2024 | -$0.09 | -$0.09 | 0 | $32.61 M | |
| 03/14/2024 | Q4 2023 | -$0.05 | $0.00 | 0.05 | $56.20 M | |
| 11/08/2023 | Q3 2023 | -$0.09 | -$0.08 | 0.01 | $48.18 M | $42.05 M |
| 08/28/2023 | Q2 2023 | -$0.06 | $59.10 M | $56.38 M | ||
| 05/08/2023 | Q1 2023 | -$0.15 | -$0.09 | 0.06 | $40.13 M | |
| 03/10/2023 | Q4 2022 | -$0.05 | $55.18 M | |||
| 11/03/2022 | Q3 2022 | -$0.15 | -$0.30 | -0.15 | $48.88 M | $48.96 M |
| 08/04/2022 | Q2 2022 | -$0.31 | $0.16 | 0.47 | $53.03 M | $126.76 M |
| 05/09/2022 | Q1 2022 | -$0.27 | -$0.37 | -0.1 | $61.70 M | |
| 03/01/2022 | Q4 2021 | -$0.33 | -$0.40 | -0.07 | $59.61 M | |
| 11/04/2021 | Q3 2021 | -$0.32 | -$0.34 | -0.02 | $49.62 M | $48.76 M |
| 08/05/2021 | Q2 2021 | -$0.30 | -$0.51 | -0.21 | $52.31 M | $52.91 M |
| 05/10/2021 | Q1 2021 | -$0.33 | -$0.45 | -0.12 | $52.30 M | |
| 02/25/2021 | Q4 2020 | -$0.43 | -$0.60 | -0.17 | $56.70 M | |
| 11/05/2020 | Q3 2020 | -$0.23 | -$0.42 | -0.19 | $84.90 M | $59.99 M |
| 08/10/2020 | Q2 2020 | -$0.46 | -$1.28 | -0.82 | $74.18 M | $90.14 M |
| 05/05/2020 | Q1 2020 | -$0.63 | -$0.47 | 0.16 | $88.48 M | |
| 03/12/2020 | Q4 2019 | -$0.79 | $69.56 M |
Akebia Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Akebia Therapeutics, Inc.'s earnings date?
Akebia Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates.
-
How can I listen to Akebia Therapeutics, Inc.'s earnings conference call?
The conference call for Akebia Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Akebia Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Akebia Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Akebia Therapeutics, Inc. generate each year?
Akebia Therapeutics, Inc. (:AKBA) has a recorded annual revenue of $194.62 M.
-
How much profit does Akebia Therapeutics, Inc. generate each year?
Akebia Therapeutics, Inc. (:AKBA) has a recorded net income of $194.62 M. Akebia Therapeutics, Inc. has generated $-0.28 earnings per share over the last four quarters.
-
What is Akebia Therapeutics, Inc.'s price-to-earnings ratio?
Akebia Therapeutics, Inc. (:AKBA) has a price-to-earnings ratio of -8.78 and price/earnings-to-growth ratio is 0.88.
